Hexachlorophen Smartpractice Europe (Hexachlorophene)

Hexachlorophen Smartpractice Europe is indicated for topical antisepsis in several minor skin conditions.

• Skin antisepsis before minor surgical procedures.
• Cleaning of minor cuts, abrasions, and lacerations.
• Prevention of infection in superficial burns.
• Preparation of skin prior to insertion of catheters or needles.
• Use on pre‑operative skin sites to reduce bacterial load.
• Daily cleansing of skin in patients with compromised barrier function.
• Application on surgical dressing edges to maintain sterility.

It may be used as part of standard wound‑care protocols to support infection control.

• Hexachlorophene exerts its antiseptic effect by integrating into bacterial cell membranes. The lipophilic molecule disrupts the lipid bilayer, increasing membrane permeability and causing leakage of intracellular contents. This destabilization interferes with essential metabolic processes, leading to a bacteriostatic effect that inhibits bacterial replication. The action is broad‑spectrum against Gram‑positive organisms and some Gram‑negative species commonly found on skin, in the superficial layers of the skin.

Topical application of hexachlorophene may be associated with local skin reactions and, rarely, systemic effects.

Common

• Mild skin irritation or redness at the application site.
• Itching or pruritus localized to the treated area.
• Dryness or peeling of the skin.
• Transient burning sensation upon application.
• Localized swelling.
• Slight discoloration of the skin.
• Temporary loss of sensation at the site.

Serious

• Allergic contact dermatitis with vesiculation and swelling.
• Systemic absorption leading to neurotoxicity, manifested as seizures (extremely rare).
• Severe skin necrosis or ulceration with prolonged use.
• Hypersensitivity reactions such as urticaria or angioedema.
• Systemic toxicity such as hepatic dysfunction has been reported with extensive exposure.

When using Hexachlorophen Smartpractice Europe, several precautions should be observed to minimize risk and ensure safe application.

• Avoid application on broken skin, open wounds, or mucous membranes.
• Do not use on large body surface areas or for prolonged periods without medical supervision.
• Keep the product out of reach of children and pets.
• Discontinue use and seek medical advice if signs of allergic reaction appear.
• Store at room temperature, protected from light and moisture.
• Use only the amount prescribed; excess may increase systemic absorption.
• Avoid use in patients with known hypersensitivity to hexachlorophene.

Hexachlorophene can interact with other topical agents or systemic medications that affect skin integrity or metabolic pathways.

Avoid

• Concurrent use with other antiseptic or keratolytic creams that may increase irritation.
• Application over areas treated with strong corticosteroids, as barrier function may be compromised.
• Use with other products containing chlorhexidine, as combined toxicity is not well studied.

Use with caution

• Patients receiving systemic antibiotics, because overlapping antimicrobial activity may mask infection signs.
• Individuals with extensive skin disease (e.g., eczema) where absorption could be higher.
• Use in combination with other neurotoxic agents, although rare, to monitor for potential additive effects.
• Patients with renal impairment should be monitored if large skin areas are treated.
• Elderly patients may have increased systemic absorption; use conservatively.